Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Vital Medical Center

Research site

Hungary József Attila u. 17., 8200 Veszprem, Hungary

  • 1 trial recruiting
  • Systemic lupus erythematosus
  • Adult patients

About Specializations

Vital Medical Center in Veszprem, Hungary specialises in clinical trials of conditions such as Systemic lupus erythematosus, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases – Systemic Lupus Erythematosus

At Vital Medical Center, investigators are conducting studies on immune system diseases, with a primary focus on systemic lupus erythematosus. The trials aim to test a new antibody treatment and monitor its safety profile.

  • Reduction of lupus disease activity
  • Long‑term safety and tolerability assessment
  • Comparison with standard of care and placebo

The research evaluates the efficacy of litifilimab (BIIB059) as an add‑on therapy for patients receiving conventional lupus care, seeking to improve outcomes and provide additional treatment options.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
József Attila u. 17.8200 VeszpremHungary
Open in maps ↗
Recruiting now
1 trial
Conditions studied
1

More sites in VeszpremHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Systemic lupus erythematosus

Recruiting

Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Systemic lupus erythematosus

Not recruiting

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.